UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen

Journal of hepatology, 2017, Vol.66 (1), p.S27-S27

2017

Link zum Volltext

Verfügbarkeit prüfen

P678 UTILITY OF QUANTITATIVE HEPATITIS B E ANTIGEN AND SURFACE ANTIGEN IN THE PREDICTION OF HEPATITIS B E ANTIGEN SEROCONVERSION FOLLOWING PREGNANCY IN HBV

Journal of hepatology, 2014-04, Vol.60 (1), p.S295-S295

2014

Link zum Volltext

Verfügbarkeit prüfen

Differential Reductions in Viral Antigens Expressed from CCCDNAVS Integrated DNA in Treatment Naïve HBEAG Positive and Negative Patients with Chronic HBV after RNA Interference Therapy with ARC-520

Journal of hepatology, 2016, Vol.64 (2), p.S390-S391

2016

Link zum Volltext

Verfügbarkeit prüfen

Predicting HBsAg Clearance Responses during ARC-520 RNA Interference (RNAI) Therapy Based on HBsAg Epitope Profile Analysis

Journal of hepatology, 2016, Vol.64 (2), p.S602-S602

2016

Link zum Volltext

Verfügbarkeit prüfen

393 MMP REGULATION BY CD147 IN HEPATOCYTES DURING CHRONIC LIVER INJURY

Journal of hepatology, 2012-04, Vol.56, p.S158-S158

2012

Link zum Volltext

Verfügbarkeit prüfen

699 COMBINATION THERAPY WITH NUCLEOS(T)IDE ANALOG REVERSE TRANSCRIPTASE INHIBITORS (NRTI): USING IN VITRO PHENOTYPING TO OPTIMISE NRTI COMBINATIONS FOR TREATMENT OF MULTIDRUG-RESISTANT HBV

Journal of hepatology, 2008, Vol.48, p.S260-S261

2008

Link zum Volltext

Verfügbarkeit prüfen

564 HIV INFECTION OF CHRONICALLY HEPATITIS B VIRUS (HBV)-INFECTED HUMAN HEPATIC AND STELLATE CELL LINES: IMPLICATIONS FOR PATHOGENESIS OF HIV-HBV CO-INFECTION

Journal of hepatology, 2009, Vol.50, p.S208-S208

2009

Link zum Volltext

Verfügbarkeit prüfen

710 DIFFERENTIAL TLR RESPONSES IN HBEAG SERCONCONVERTERS WITHIN 4 WEEKS OF PEGYLATED IFN THERAPY

Journal of hepatology, 2008, Vol.48, p.S265-S265

2008

Link zum Volltext

Verfügbarkeit prüfen

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

Antiviral research, 2007-11, Vol.76 (2), p.168-177

2007

Link zum Volltext

Verfügbarkeit prüfen

The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia

Journal of gastroenterology and hepatology, 2013-07, Vol.28 (7), p.1234-1241

2013

Link zum Volltext

Verfügbarkeit prüfen

PS-045 - Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen

Journal of hepatology, 2017, Vol.66 (1), p.S27-S27

2017

Link zum Volltext

Verfügbarkeit prüfen

THU-193 - Differential Reductions in Viral Antigens Expressed from CCCDNAVS Integrated DNA in Treatment Naïve HBEAG Positive and Negative Patients with Chronic HBV after RNA Interference Therapy with ARC-520

Journal of hepatology, 2016, Vol.64 (2), p.S390-S391

2016

Link zum Volltext

Verfügbarkeit prüfen

FRI-144 - Predicting HBsAg Clearance Responses during ARC-520 RNA Interference (RNAI) Therapy Based on HBsAg Epitope Profile Analysis

Journal of hepatology, 2016, Vol.64 (2), p.S602-S602

2016

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients

Journal of clinical virology, 2005-02, Vol.32 (2), p.122-127

2005

Link zum Volltext

Verfügbarkeit prüfen

Critical determinants of activity of purine and pyrimidine nucleoside analogs which inhibit replication of hepatitis B virus (HBV) and human immunodeficiency virus (HIV)

Clinical biochemistry, 1997-04, Vol.30 (3), p.279-279

1997

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility of HIV to inactivation by disinfectants and ultraviolet light

The Journal of hospital infection, 1995-07, Vol.30 (3), p.167-180

1995

Link zum Volltext

Verfügbarkeit prüfen

Abnormal Laboratory Results: Hepatitis C: diagnosis and monitoring

Australian prescriber, 1999-08, Vol.22 (4), p.91-94

1999

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation

Hepatology research, 1997-06, Vol.7 (2), p.139-139

1997

Link zum Volltext

Verfügbarkeit prüfen

Chapter 123 - Animal Models for Hepatitis B Infections — Duck Hepatitis

Handbook of Animal Models of Infection, 1999, p.1021-1031

1999

Link zum Volltext

Verfügbarkeit prüfen

Restrictive events in the replication of hepatitis A virus in vitro

Intervirology, 1985, Vol.24 (1), p.26

1985

Link zum Volltext

Verfügbarkeit prüfen

A Solid-Phase Enzyme-Linked immunosorbent assay (ELISA) for detection of antibody to rubella virus

Pathology, 1979-01, Vol.11 (3), p.393-399

1979

Link zum Volltext

Verfügbarkeit prüfen

PITFALLS IN HEPATITIS A?

The Lancet (British edition), 1974-10, Vol.304 (7887), p.1007-1007

1974

Link zum Volltext

Verfügbarkeit prüfen

Autoantibody to intermediate filaments in viral hepatitis

Clinical immunology and immunopathology, 1981-01, Vol.21 (2), p.154-161

1981

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(22)
Buchkapitel
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen

P678 UTILITY OF QUANTITATIVE HEPATITIS B E ANTIGEN AND SURFACE ANTIGEN IN THE PREDICTION OF HEPATITIS B E ANTIGEN SEROCONVERSION FOLLOWING PREGNANCY IN HBV

Differential Reductions in Viral Antigens Expressed from CCCDNAVS Integrated DNA in Treatment Naïve HBEAG Positive and Negative Patients with Chronic HBV after RNA Interference Therapy with ARC-520

Predicting HBsAg Clearance Responses during ARC-520 RNA Interference (RNAI) Therapy Based on HBsAg Epitope Profile Analysis

393 MMP REGULATION BY CD147 IN HEPATOCYTES DURING CHRONIC LIVER INJURY

699 COMBINATION THERAPY WITH NUCLEOS(T)IDE ANALOG REVERSE TRANSCRIPTASE INHIBITORS (NRTI): USING IN VITRO PHENOTYPING TO OPTIMISE NRTI COMBINATIONS FOR TREATMENT OF MULTIDRUG-RESISTANT HBV

564 HIV INFECTION OF CHRONICALLY HEPATITIS B VIRUS (HBV)-INFECTED HUMAN HEPATIC AND STELLATE CELL LINES: IMPLICATIONS FOR PATHOGENESIS OF HIV-HBV CO-INFECTION

710 DIFFERENTIAL TLR RESPONSES IN HBEAG SERCONCONVERTERS WITHIN 4 WEEKS OF PEGYLATED IFN THERAPY

The phenylpropenamide derivative AT-130 blocks HBV replication at the level of viral RNA packaging

The molecular epidemiology of hepatitis B in the Indigenous people of northern Australia

PS-045 - Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen

THU-193 - Differential Reductions in Viral Antigens Expressed from CCCDNAVS Integrated DNA in Treatment Naïve HBEAG Positive and Negative Patients with Chronic HBV after RNA Interference Therapy with ARC-520

FRI-144 - Predicting HBsAg Clearance Responses during ARC-520 RNA Interference (RNAI) Therapy Based on HBsAg Epitope Profile Analysis

Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients

Critical determinants of activity of purine and pyrimidine nucleoside analogs which inhibit replication of hepatitis B virus (HBV) and human immunodeficiency virus (HIV)

Susceptibility of HIV to inactivation by disinfectants and ultraviolet light

Abnormal Laboratory Results: Hepatitis C: diagnosis and monitoring

Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation

Chapter 123 - Animal Models for Hepatitis B Infections — Duck Hepatitis

Restrictive events in the replication of hepatitis A virus in vitro

A Solid-Phase Enzyme-Linked immunosorbent assay (ELISA) for detection of antibody to rubella virus

PITFALLS IN HEPATITIS A?

Autoantibody to intermediate filaments in viral hepatitis

Suchergebnisse filtern